Application Nr Approved Date Route Status External Links
ANDA210790 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Levomilnacipran Is Indicated For The Treatment Of Major Depressive Disorder (Mdd) In Adults [See Clinical Studies (14) ] . Limitation Of Use : Levomilnacipran Extended-Release Capsules Are Not Approved For The Management Of Fibromyalgia. The Efficacy And Safety Of Levomilnacipran Extended-Release Capsules For The Management Of Fibromyalgia Have Not Been Established. Levomilnacipran Is A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For The Treatment Of Major Depressive Disorder (Mdd) In Adults (1) . Limitation Of Use : Levomilnacipran Extended-Release Capsules Are Not Approved For The Management Of Fibromyalgia. The Efficacy And Safety Of Levomilnacipran Extended-Release Capsules For The Management Of Fibromyalgia Have Not Been Established (1) .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levomilnacipran Hydrochloride LEVOMILNACIPRAN HYDROCHLORIDE ZINC506

Comments